Prescription drug · ANDA
Fluocinonide NDC 45802-761
Fluocinonide .5 mg/g · Gel · Topical · Padagis Israel Pharmaceuticals Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 45802-761-15 | 45802076115 | 1 TUBE in 1 CARTON (45802-761-15) / 15 g in 1 TUBEMarketed from Apr 10, 2025 | |
| 45802-761-30 | 45802076130 | 1 TUBE in 1 CARTON (45802-761-30) / 30 g in 1 TUBEMarketed from Apr 10, 2025 | |
| 45802-761-60 | 45802076160 | 1 TUBE in 1 CARTON (45802-761-60) / 60 g in 1 TUBEMarketed from Apr 10, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluocinonide
- Generic name (nonproprietary)
- fluocinonide
- Active ingredients
- Fluocinonide — .5 mg/g
- Dosage form
- Gel
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209030
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 45802-761_9f42e872-a537-4ef0-85f0-7c5e0445a92aSPL ID 9f42e872-a537-4ef0-85f0-7c5e0445a92aSPL set ID 8e22600e-a1a2-432c-a47c-b7b99a0b1e46RxCUI 310362UNII 2W4A77YPAN
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N445802076115followed by a unit qualifier and the quantityPackage 45802-0761-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Fluocinonide Gel USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.